|
| 
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
 |
Building sustainable competitive advantage in biotechnology
 |
|
| The biotech industry is often referred to as the business of science; young and sexy, attracting the attention of both investors and researchers alike. However, underneath the shine is an industry often associated with failed returns and promises. |
|
|
|
|
|
Managing talent when things get tough
|
|
| The global pharma and biotech industry typically responds to an economic downturn by downsizing its talent pool; although the 2008 financial crisis did not result in layoffs within Asias biomedical sector, many companies saw headcount freezes |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
James M. Mash appointed as regional director of PACRA
|
|
| Asia Global Research (AGR), a clinical research organization (CRO) in Asia, has announced that Mr James M Mash, its CEO, has been appointed as Regional Director of Pan-Asian Clinical Research Association (PACRA). |
|
|
|
|
|
RSA Singapore appoints new Managing Director
|
|
| RSA, the global life sciences executive search and interim management specialist, has announced that Susan Macdonald has took up the role of Managing Director of RSA Singapore on 1st August 2010. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
|
|
UK-Singapore organizes symposium on Medicinal Chemistry
|
|
| The Royal Society of Chemistry, in collaboration with A*STARs Institute of Chemical and Engineering Sciences and GlaxoSmithKline R&D, Singapore and with support from the British High Commission Singapore organized a symposium on Medicinal Chemistry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
Gamma-Tocotrienol kills prostate cancer stem cells
|
|
| Scientists from Singapore, Australia and Hong Kong have found that gamma-tocotrienol is potent in killing prostate cancer stem cells. This small group of cells is responsible for the initiation of prostate cancer and is resistant to chemotherapy drug |
|
|
|
|
|
Nanotech R&D grows in personal care industry
|
|
| Small particles are becoming a big business for the worlds personal care products manufacturers according to an analysis of world patent activity published by the IP Solutions business of Thomson Reuters. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
India tightens approval mechanism of clinical trials
|
|
| India's pharmaceutical regulator, the Drugs Controller General of India (DCGI), has tightened the approval mechanism for clinical trials and marketing licenses for biotechnology drugs, medical devices and vaccines in the country |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
Shimadzu launches green UHPLC
|
|
| Expanding its product portfolio, Japan-based Shimadzu Corporation, engaged in the development of advance technologies, has announced the launch of Nexera, an Ultra High Performance Liquid Chromatograph (UHPLC) |
|
|
|
|
|
Mindray Medical launches four new products in H1 2010
|
|
| Mindray Medical International, a leading developer, manufacturer and marketer of medical devices worldwide, announced that in the first half of the year, it has successfully released a total of four products across its three product lines. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
M&As on the rise in APAC healthcare markets: Datamonitor
|
|
| The sheer size and purchasing power of patient populations in emerging Asia Pacific healthcare markets, combined with improving regulatory and business environments, is attracting pharmaceutical companies from far and wide, says Datamonitor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
